Bill
HB 2072
Sustaining and expanding behavioral health services by levying an opioid impact fee on opioid manufacturers.
2025-2026 Regular Session
Introduced by Lauren Davis and 2 co-sponsors
Washington HB 2072 imposes a fee on opioid manufacturers to fund expanded behavioral health and addiction treatment services statewide.
First reading, referred to Appropriations.